Free Trial

EUROFINS SCIENT (OTCMKTS:ERFSF) Shares Gap Up - Still a Buy?

Eurofins Scient logo with Medical background

Key Points

  • Eurofins Scient shares gapped up prior to trading, opening at $77.09, up from a previous close of $73.81.
  • Citigroup maintained a "neutral" rating on Eurofins Scient, with an overall average rating of "Hold" from analysts, including one Strong Buy rating.
  • The company has solid liquidity ratios, with a quick ratio of 1.19 and a current ratio of 1.26, while their two-hundred day moving average stands at $66.43.
  • MarketBeat previews top five stocks to own in November.

EUROFINS SCIENT (OTCMKTS:ERFSF - Get Free Report)'s stock price gapped up before the market opened on Monday . The stock had previously closed at $73.81, but opened at $77.09. EUROFINS SCIENT shares last traded at $77.09, with a volume of 150 shares traded.

Analyst Upgrades and Downgrades

Separately, Citigroup reaffirmed a "neutral" rating on shares of EUROFINS SCIENT in a research report on Friday, July 25th. One analyst has rated the stock with a Strong Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Hold".

Read Our Latest Stock Analysis on ERFSF

EUROFINS SCIENT Stock Up 1.9%

The business's 50 day moving average price is $76.18 and its 200-day moving average price is $67.01. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.19 and a current ratio of 1.26.

About EUROFINS SCIENT

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

Further Reading

Should You Invest $1,000 in Eurofins Scient Right Now?

Before you consider Eurofins Scient, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eurofins Scient wasn't on the list.

While Eurofins Scient currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.